Condition: ADNP · Helsmoortel-Van Der Aa Syndrome · Autism Spectrum Disorder · Sponsor: Icahn School of Medicine at Mount Sinai
ADNP, also known as Activity Dependent Neuroprotective Protein, is a rare neurodevelopmental disorder caused by mutations encompassing the ADNP gene on chromosome 20. Clinically, ADNP syndrome is characterized by intellectual disability and global developmental delay. This study seeks to characterize ADNP-related neurodevelopmental disorders using a number of genetic, medical and neuropsychological measures.
This description comes directly from the study's public registry record.
Tess Levy · 212-241-5290 · tess.levy@mssm.edu
Always discuss trial participation with your own doctor first.
| The Seaver Autism Center for Research and Treatment | New York, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03718936